Radiomic biomarkers for platinum-refractory head and neck cancer in the era of immunotherapy.
Sign Up to like & getrecommendations! Published in 2024 at "Oral diseases"
DOI: 10.1111/odi.14854
Abstract: OBJECTIVE Immune checkpoint inhibitors (ICI) are recommended as the first-line therapy for platinum-refractory head and neck squamous cell carcinoma (HNSCC), a disease with a poor prognosis. However, biomarkers in this situation are rare. The objective… read more here.
Keywords: head neck; radiomic features; platinum refractory; refractory head ... See more keywords